Literature DB >> 18669987

Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease.

Richard Morriss, Benson Benjamin.   

Abstract

The National Strategic Framework for Renal Services introduced the routine reporting of estimated glomerular filtration rates (eGFR) on serum urea and electrolyte tests. Estimated glomerular filtration rates might reduce renal failure induced by lithium and cardiovascular mortality but there are many false positives. We propose how eGFR might be used in lithium monitoring.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669987     DOI: 10.1192/bjp.bp.108.051268

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  4 in total

1.  Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines.

Authors:  Rachael W Taylor; Lindsey Marwood; Emanuella Oprea; Valeria DeAngel; Sarah Mather; Beatrice Valentini; Roland Zahn; Allan H Young; Anthony J Cleare
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

Review 2.  Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety.

Authors:  Etienne Marc Grandjean; Jean-Michel Aubry
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

3.  Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders.

Authors:  Emanuel Severus; Michael Bauer
Journal:  BMC Med       Date:  2013-02-11       Impact factor: 8.775

Review 4.  Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification.

Authors:  J Davis; M Desmond; M Berk
Journal:  BMC Nephrol       Date:  2018-11-03       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.